Serotonin and dopamine as mediators of sensation seeking behavior

Neuropsychobiology

Volumn 34, Issue 3, 1996, Pages 155-165

  Netter, P ^a   Hennig, P ^a   Roed, I S ^b  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b BAYER PHARMA AG   (Germany)

Author keywords

Challenge tests; Cortisol; Dopamine; Nicotine deprivation; Prolactin; Sensation seeking; Serotonin

Indexed keywords

DOPAMINE; FLUPHENAZINE; HYDROCORTISONE; IPSAPIRONE; LISURIDE; NEUROTRANSMITTER; NICOTINE; PROLACTIN; SEROTONIN;

AGGRESSION; AROUSAL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; EMOTION; FACTORIAL ANALYSIS; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; IMPULSIVENESS; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROVOCATION TEST; SEROTONINERGIC SYSTEM; SMOKING CESSATION;

EID: 0029906588     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000119318     Document Type: Article

References (58)

1. Asberg M, Traskman L, Thorcn P: 5-HIAA in the cerebrospinal fluid, A biochemical suicide predictor? Arch Gen Psychiatry 1976.33: 1193-1197.
2. Linnoila M, Virkkunen M, Schcinin M, Nuuti-la A, Rimon R, Goodwin FK: Low cerebrospinal fluid 5-hydroxyindoleaceticacid concentration differentiates impulsive from nonimpul-sive violent behavior, Life Sci 1983:33:2609-2614.
3. Coccaro EF, Siever LJ, Klar H, Maurer G, Rubinstein K, Cooper TB, Mohs RC, Davis KL: Serotonergic studies in affective and personality disorder patients: Correlates with behavioral aggression and impulsivity, Arch Gen Psychiatry 1989:46:587-599.
4. O'Keane V, Moloney E, O'Neill H, O'Connor A: Blunted prolactin responses to β-fenfluramine in sociopathy: Evidence for subsensitivity of central serotonergic function, Br J Psychiatry 1992:160:643-646.
5. Moss MB, Yao JK, Panzak GL: Serotonergic rcsponsivity and behavioral dimensions in antisocial personality disorder with substance abuse, Biol Psychiatry 1990:28:325-338.
6. Hollander E, deCaria CM, Schncicr FR, Schneider HA, Liebowitz MR, Klein DF: Fenfluramine augmentation of serotonin reuptake blockade antiobsessional treatment, J Clin Psychiatry 1990;51(3):119-123.
7. O'Keane V, Dinan TG: Prolactin and cortisol responses to β-fenfluramine in major depression: Evidence for diminished rcsponsivity of central serotonergic function, Am J Psychiatry 1991:148:1009-1015.
8. Lopez-Ibor JL: The involvement of serotonin in psychiatric disorders and behavior, Br J Psy-chia.ry 1988:153(3):26-39.
9. Fishbein DH, Lozovsky D, Jaffe JH: Impulsivity, aggression, and neuroendocrine responses to serotonergic stimulation in substance abusers, Biol Psychiatry 1989:25:1049-1066.
10. Stoff DM, Pasatiempo AP, Yeung J, Cooper TB, Bridger WH, Rabinovich H: Neuroendocrine responses to challenge with //-fenfluramine and aggression in disruptive behavior disorders of children and adolescents, Psychiatry Res 1992;43:263-276.
11. Schalling D, Asberg M, Edman G, Levandcr S: Impulsivity, nonconformity, and sensation seeking as related to biological markers for vulnerability, Clin Ncuropharmacol 1984:7:746-747.
12. Dcpue RA, Spoont MR: Conceptualizing a serotonin trait: A behavioral dimension of constraint, Ann NY Acad Sci 1986:487:47-62.
13. Depue RA, Zald DU: Biological and environmental processes in nonpsychotic psychopathology: A ncurobehavioral system perspective; in Costello CG (ed): Basic Issues in Psychopathology, New York, Guilford, 1993, pp 127-137.
14. Hcgerl U, Gallinat J, Juckel G, Lippcrhcide K, Schmidt LG, Rommelspacher H: Personality, serotonin, and auditory evoked electrical dipole activity, Pharmacopsychiatry 1995,28: 185.
15. Netter P: Ritanserin, a 5-HT; blocker w ith personality dependent agonistic effects? Psychopharmacology 1988:96:244.
16. Netter P, Hcnnig J, Laschefski U: Cortisol and prolactin responders to 5-HT agonist stimulation, Behav Pharmacol 1994:5(1):82.
17. Mason ST: Catecholamines and Behavior, Cambridge, Cambridge University Press, 1984.
18. Eichelman B: The role of biogenic amines in aggressive behavior; in Sandler M (ed): Psychopharmacology of Aggression, New York, Raven Press, 1979, pp 61-93.
19. Eichelman B: Ncurochcmical and psychophar-macologieal aspects of aggressive behavior; in Meltzcr HY (ed): Psychopharmacology: The Third Generation of Progress, New York, Raven Press, 1987, pp 697-704.
20. Singhal RL, Telncr Jl: A perspective: Psycho-pharmacological aspects of aggression in animals and man, Psychiatr J Univ Ottawa 1983: 8:146-154.
21. Crawley JN, Contrera JF: Intraventricular 6-hydroxydopamine lowers isolation-induced fighting behavior in male mice, Pharmacol Bio-chem Behav 1976;4:381-384.
22. Barr GA, Sharpless NS, Gibbons JL: Differences in the level of dopamine in the hypothalamus of aggressive and non-aggressive rats, Brain Res 1979:166:211-216.
23. Goodwin FK, Murphy DL, Brodie HKH, Bun-ney WE: Z.-DOPA, catecholamines, and behavior: A clinical and biochemical study in depressed patients, Biol Psychiatry 1970:2:341-366.
24. Depue RA: Neurobiological factors in personality and depression, Eur J Pcrs 1995:9:413-439.
25. Tellegen A: Structures of mood and personality and their relevance to assessing anxiety, with an emphasis on self-report; in Tuma A, Maser JD (eds): Anxiety and the Anxiety Disorders, Hillsdale, Erlbaum, 1985, pp 681-706
26. Zuckerman M: Psychobiology of Personality, Cambridge, Cambridge University Press, 1991.
27. Zuckerman M: Behavioral Expressions and Biosocial Bases of Sensation Seeking, New York, Cambridge University Press, 1994
28. Zuckerman M: Personality in the third dimension: A psychobiological approach, Pers Individ Diff 1989:10:391-418.
29. Zuckerman M, Kuhlman DM, Thomquist M, Kiers H: Five (or three) robust questionnaire scale factors of personality without culture, Pers Individ DitT 1991; 12:929-942.
30. Bozarth MA: The mcsolimbic dopamine system as a model reward system: in Willncr P, Scheel-Kriigcr J (eds): The Mcsolimbic Dopamine System: Form Motivation to Action, Chichester, Wiley, 1991, pp 301-330.
31. Cador M, Robbins TW, Evcritt BJ, Simon H, LcMoal M, Stinus L: Limbic-slratial interactions in reward-related processes: Modulation by the dopaminergic system; in Willner P, Scheel-Kriigcr J (eds): The Mcsolimbic Dopaminergic System: From Motivation to Action, Chichester, Wiley, 1991, pp 225-250.
32. Cloningcr CR: A systematic method for clinical description and classification of personality variants, Arch Gen Psychiatry 1987:44:573-588.
33. Wiesbcck GA, Maucrer C, Thome J, Jakob F, Boening J: Sensation seeking, alcoholism, and dopamine activity, Eur Psychiatry, in press
34. Netter P, Rammsayer T: Serotonergic effects on sensory and motor responses in cxlravcrts and introverts, Int Clin Psvchopharmacol 1989;4(1):21-26.
35. Netter P, Rammsayer T: Reactivity to dopaminergic drugs and aggression related personality traits, Pers Individ Diff 1991:12:1009-1017.
36. Eysenck SBG, Eysenck HJ: Impulsiveness and venturesomeness, Their position in a dimensional system of personality description, Psychol Rep 1978:43:1247-1255.
37. Fahrenberg J, Hampel R, Sclg H: Das Freiburger Persönlichkeitsinventar FPL Revidierte Fassung FP1-R, Göttingen, Hogrefe, 1984
38. Eysenck SBG, Eysenck HJ, Barrett P: A revised version of the psvchoticism scale, Pcrs Individ Diff 1985;6:21-29.
39. Kirschbaum C, Strasburger SJ, Jammers W, Hellhammer DH: Cortisol and behavior, 1, Adaptation of a radioimmunoassay kit for reliable and inexpensive salivary cortisol determination, Pharmacol Biochcm Behav 1989:34:747-751.
40. Janke W, Debus G: Die Eigcnschaftsworterliste (EWL): Ein Verfahren zur Erfassung der Befindlichkeit, Göttingen, Hogrefc, 1978.
41. Olivier B, Mos J, van Oorschot R, Hen R: Serotonin receptors and animal models of aggressive behavior, Pharmacopsychiatry 1995:28: 80-90.
42. Imperato A, Mulas A, Di C'hiara G: Nicotine preferentially stimulated dopamine release in the limbic system of freely moving rats, Eur J Pharmacol 1986:132:337-338.
43. Corrigall WA: Regulation of intravenous self-administration-dopamine mechanisms; in Adl-kofer F, Thurau K (eds): Effects of Nicotine on Biological Systems, Basel, Birkhäuscr, 1991, pp 423-432.
44. Dawe S, Gcrada C, Russell MA, Gray JA: Nicotine intake in smokers increases following a single dose of haloperidol, Psychopharmacology (Berlin) 1995:117:110-115.
45. Hcnnig J, Netter P: The role of the 5-HTi„-reccptor for cortisol release, Pharmacopsychiatry 1995:28:187.
46. Janke W, Erdmann G, Kallus KW: Der Stressverarbeitungsfragebogen SVF, Göttingen, Hogrefe, 1985.
47. Coccaro EF: Impulsive aggression and central serotonergic system function in humans: An example of a dimensional brain behavior relationship, Int Clin Psvchopharmacol 1992:7:3-12.
48. 1α receptor challenge in major depression and suicidal behavior, Pharmacopsychiatry 1995:28:91-92.
49. 1α receptor responsivity in unipolar depression, Evaluation of ipsapirone induced ACTH and cortisol secretion in patients and controls, Biol Psychiatry 1990:28:620-628.
50. Rupprccht R, Lesch KP, Müller U, Beck G, Beckmann H, Schulte HM: Blunted adrcnocor-ticotropin but normal b-endorphin release after human corticotropin-releasing hormone administration in depression, J Clin Endocrinol Metab 1989;69:600-603.
51. C'owcn PJ, Anderson IM: Abnormal 5-HT neuroendocrine function in depression: Association or artefact?: in Sandler M, Coppcn A, Harnett S (eds): 5-Hydroxvtryptaminc in Psychiatry, A Spectrum of Ideas, Oxford, Oxford University Press, 1992, pp 124-142.
52. Palazidou E, Stephenson J, Butler J, Coskcran P, Chambers S, McGregor AM: Evidence for 5-hydroxytryptaminei, receptor involvement in the control of prolactin secretion in man, Psychopharmacology (Berlin) 1995:1 19:311-314.
53. Hudgel DW, Gordon EA, Meitzer HY: Abnormal serotonergic stimulation of cortisol production in obstructive sleep apnea, Am J Re-spir Crit Care Med 1995:152(1): 186-192.
54. Wernicke JF: The side effect profile and the safety of fluoxetine, J Clin Psychiatry 1985:40: 59-67.
55. Silverstone PH, Rue JE, Franklin M, Hallis K, Camplin G, Laver D, Cowen PJ: The effects of administration of mCPP on psychological, cognitive, cardiovascular, hormonal, and MHPG measurements in human volunteers, Int Clin Psychopharmacol 1994:9(3): 173-178.
56. Cools AR, Rots NY, Ellenbroek D, dc Kloct ER: Bimodal shape of individual variation in behavior of Wistar rats: The overall outcome of a fundamentally different make-up and reactivity of the brain, the endocrinological, and the immunological system, Neuropsychobiology 1993;28:100-105
57. Robinson TE, Bcrridgc KC: The neural basis of drug craving: An incentive sensitization theory of addiction, Brain Res Brain Res Rev 1993; 18:247-291.
58. Ebstein RP, Novick O, Umansky R, Priel B, Osher Y, Blaine D, Bennett ER, Ncmanov L, Katz M, Belmakcr RI I: Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of novelty-seeking, Nat Genet 1996:12:78-80.